About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, November 14th, 2012

The QualityStocks
Daily Stock List


TNR Gold Corp. (TNR.V)

We are highlighting TNR Gold Corp. (TNR.V), here at the QualityStocks Daily Newsletter.

TNR Gold Corp. is a mineral exploration company whose shares trade on the TSX Venture Exchange. The Company is actively pursuing a portfolio of gold, copper, and Rare Earth Element (REE) containing properties around the world. Their primary focus is in the exploration and development of their key ventures. These include the Shotgun gold project in Alaska, TNR iron ore and REE projects in Soules Bay, Canada and the Company's ongoing project generator in Argentina. TNR Gold has their corporate headquarters in Vancouver, British Columbia.

The Company's strategy is to strengthen their assets through partnerships with mid-tier and major companies, and establish long-term cash flow through royalty interests and project development. TNR Gold's recently listed subsidiary, International Lithium Corp. (ILC.V), demonstrated the successful application of the Company's business model in which TNR shareholders benefited from a unit distribution upon spin-out of TNR's lithium and rare metals projects. TNR Gold remains a large shareholder in ILC at 25.5 percent of outstanding shares.

Concerning the Shotgun gold project in Alaska, TNR currently holds a 100 percent interest in this property. Shotgun is 175 km south of Donlin Creek within the Kuskokwim Gold Belt in Southwestern Alaska. The Shotgun property includes several prospects, including Shotgun Ridge and nearby Winchester. The IIiamna project is in Southwestern Alaska. It is an early-stage exploration project; Iliamna is a drill ready copper-gold porphyry target with size potential.

The Company's Soules Bay project is almost 300 km north of Thunder Bay, Ontario. The property contains a 12 km highly magnetic iron strike formation and lies adjacent to a historical reserve of 628 million tonnes grading 23.1 percent soluble iron. The Property occurs within the eastern Lake St. Joseph Greenstone Belt in the Uchi Subprovince of the Superior Province of the Canadian Shield.

The Los Azules project is an advanced-stage porphyry copper exploration project located in the cordilleran region of San Juan Province, Argentina, near the border with Chile. It has ranking as the sixth largest undeveloped copper deposit in the world. Los Azules has a mineral resource of 10.3 billion pounds of copper (inferred) and 2.2 billion pounds of copper (indicated).

This week, TNR Gold announced that they, and their wholly owned subsidiary, Solitario Argentina S.A., reached a settlement with McEwen Mining, Inc. This resolves the outstanding litigation with respect to the Los Azules Copper Project located in San Juan Province, Argentina. The settlement restores a 25 percent back-in right to TNR that is exercisable following the completion of a feasibility study. Additionally, TNR receives an industry standard Net Smelter Royalty (NSR) of 0.6 percent and 1 million shares in McEwen Mining. In return, TNR will discontinue their claims and transfer to McEwen Mining the mineral rights to a property called Escorpio IV.

TNR Gold Corp. (TNR.V), closed Wednesday’s session at $0.095, even for the day, on 456,800 volume. The stock's 52-week low/high is $0.04/$0.15.

Harmonic Energy, Inc. (ASUV)

Investors Online Bell and UltimatePennyStock reported this week on Harmonic Energy, Inc. (ASUV), Wyatt Investment Research, Lion of Wall Street, Trade of the Week, Investors Alley, Terry's Tips, and StreetAuthority Financial also reported this month, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Harmonic Energy, Inc. is a project development enterprise whose shares trade on the OTC Markets: OTCQB. The Company provides a complete solution to the disposal of scrap tires worldwide. Their solution combines technologies that ensure that each scrap tire is either remanufactured and put on the road as a new tire, or is recycled and reduced into marketable chemical commodity products. Harmonic Energy is based in London, England.

The tire remanufacturing and the Tyrolysis™ technology that the Company utilizes are commercially proven and in operation independently worldwide. Harmonic Energy is now working on funding the upgrades for the first of ten plants that they plan for North America and Europe in the next five years.

A small, modular Harmonic Energy plant will dispose of scrap ties without government, consumer or industry subsidies. It will also produce carbon credits. In addition, a plant will produce 250,000 new quality tires at less than 50 percent of the cost of new tires. These tires will have the same warranty.

Furthermore, a single plant will produce millions of liters of refined diesel fuel each year. It will also produce millions of kilograms of carbon black. The Tyrolysis™ process applies heat to either whole or shredded scrap tires in an inert, nitrogen environment. This causes the tire to thermally decompose and degrade into their original components of different carbon blacks in the form of char, oil, gas, as well as steel. This is without any burning or combustion of the tire.

Last week, Harmonic Energy announced that they successfully negotiated a Lease Option Agreement for a 10-acre site in Ohio. The site features several positive attributes that makes it an ideal site for the Company's expansion plans. The property features rail access and has an in-yard rail spur option that can be easily upgraded to fit Harmonic Energy's needs. The site is directly on State Rt. 224; it features quick access to I-77, I-76 and the Ohio Turnpike. The site is an active oil terminal tank farm property with the capability and permits to store more than 5 million gallons of oil onsite.

Harmonic Energy, Inc. (ASUV), closed Wednesday’s session at $0.94, up 4.44%, on 124,117 volume with 84 trades. The average volume for the last 60 days is 43,259 and the stock's 52-week low/high is $0.09/$3.00.

Bayport International Holdings, Inc. (EXTO)

PennyTrader Publisher reported recently on Bayport International Holdings, Inc. (EXTO), Bull in Advantage did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Las Vegas, Nevada, Bayport International Holdings, Inc. is a multi-faceted holding company. Bayport is active in strategic metals and precious minerals, energy production, wholesale seafood sales, natural foods processing, health and beauty products. Primarily, the Company is focusing on precious metals, rare earth, and other critical strategic metals. Bayport International Holdings lists on the OTC Markets: OTC Pink Current Information.

The Company is developing mining properties with economic potential with the goal of bringing these properties to commercial production. Their property portfolio is mainly in the prolific Western United States. The Company began in 2004.  On July 7, 2011, Bayport International Holdings took control of Exit Only, Inc., a Nevada public company.

Bayport primarily consists of two distinct divisions. These divisions consist of the Mining Division and the Oil & Gas Division. The Food Processing Division and the Innovative Projects Division are part of future projects the Company is working on. The main focus of Bayport is their mining projects. These include the WOW, Spring Sage, and Gilded Lady mining projects. The WOW, Spring Sage, and Gilded Lady claims are all in Sage Valley within the Salt Lake Meridian Township in Juab County.  The WOW claims account for 120 acres; the Spring Sage Claims account for 640 acres; and the Gilded Lady Claims account for 168.44 acres.

The Company has agreed in principle to combine the oil and gas divisions with that of a Texas oil & gas company. This is to form a more complete division, combining landmen and field personnel with Bayport's own oil & gas team.  The Company will have an oil & gas field office in Diboll, Texas. This division will actively pursue leases and oil & gas drilling opportunities and will similarly pursue saltwater disposal well projects.

Recently, Bayport announced the culmination of the first round of comprehensive testing and assay results. The Company has filed with the Bureau of Land Management (BLM) and State of Utah, Department of Natural Resources, Division of Oil, Gas and Mining to start small mining operations on the first few of their mining claims. The Company has assay results from Auric Metallurgical Laboratories. The first of the claims tested shows quantities of gold at 0.279 troy ounces per ton and Silver at 0.267 troy ounces per ton. In addition to the gold and silver, potentially profitable levels of magnetite (iron ore); palladium, and other rare earth elements have been shown to exist in the claim.

Bayport International Holdings, Inc. (EXTO), closed Wednesday’s session at $0.0017, up 21.43%, on 690,100 volume with 9 trades. The average volume for the last 60 days is 3,328,714 and the stock's 52-week low/high is $0.0008/$0.009.

Ladenburg Thalmann Financial Services, Inc. (LTS)

Wall Street Resources reported recently on Ladenburg Thalmann Financial Services, Inc. (LTS), Fast Moving Stocks, StockRunway, MajorPennyStocks, PennyTrader Publisher did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Ladenburg Thalmann Financial Services, Inc. engages in independent brokerage and advisory services, investment banking, equity research, institutional sales and trading, and asset management services. The Company performs this by way of their principal subsidiaries, Ladenburg Thalmann & Co., Inc., Investacorp, Inc., Triad Advisors, Inc., and Securities America, Inc. Ladenburg Thalmann lists on the NYSE Market; the Company has their corporate headquarters in Miami, Florida.

Ladenburg Thalmann & Co. is a full service investment banking and brokerage firm. This subsidiary provides services mainly for middle market and emerging growth companies and high net worth individuals. They focus on Investment Banking, Equity Research, Institutional Sales & Trading, and Private Client Services. Ladenburg Thalmann & Co. has their headquarters in New York, New York with regional offices in Miami, Naples, and Boca Raton, Florida; Melville, New York; Houston, Texas; Calabasas, California; Boston, Massachusetts, and Princeton, New Jersey.

Investacorp is a leading independent broker-dealer with headquarters in Miami. This subsidiary has been serving the independent registered representative community since 1978.

Triad Advisors is a leading independent broker-dealer and registered investment advisor with headquarters in Norcross, Georgia. Triad offers an extensive menu of products, services, as well as total wealth management solutions. Headquartered in Omaha, Nebraska, Securities America (founded in 1984) is one of the largest and most successful independent broker-dealers in the U.S. This subsidiary has more than 1,700 financial professionals across the nation.

Last week, Ladenburg Thalmann Financial Services announced financial results for the three and nine months ended September 30, 2012. Third quarter 2012 revenues were $159.8 million, a 227 percent increase from revenues of $48.9 million in the third quarter of 2011. Net loss for the third quarter was $6.0 million or $(0.03) per basic and diluted share, compared to a net loss of $3.1 million, or $(0.02) per basic and diluted share in the comparable 2011 period.

For the nine months ended September 30, 2012, they had revenues of $477.9 million, a 187 percent increase over revenues of $166.3 million for the comparable 2011 period. They had a net loss of $14.0 million or $(0.08) per basic and diluted share for the nine months ended September 30, 2012, compared to a net loss of $2.5 million or $(0.01) per basic and diluted share in the comparable 2011 period.

Ladenburg Thalmann Financial Services, Inc. (LTS), closed Wednesday’s session at $1.17, down 4.88%, on 460,182 volume with 1,100 trades. The average volume for the last 60 days is 219,324 and the stock's 52-week low/high is $1.16/$2.94.

Calypte Biomedical Corp. (CBMC)

Stockpalooza, OTC Picks, FeedBlitz, and MicrocapVoice reported previously on Calypte Biomedical Corp. (CBMC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Founded in 1988, Calypte Biomedical Corp. develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases. During the second quarter of 2012, the Company continued to focus on their research and development operations, and building upon the promising results of the completed internal trials of their new Aware™ 2 HIV-1/2 oral fluid rapid test, which showed an accuracy of 100 percent. Calypte Biomedical has contacted the FDA and started the process to conduct clinical trials. The Company is based in Portland, Oregon; their shares trade on the OTCQB.

Calypte Biomedical's product line includes point-of-case rapid tests and traditional ELISA/EIA diagnostic tests. In addition, the Company offers a wide spectrum of recombinant proteins and antigens and proprietary reagents, buffers, and other specialty products. They offer these to researchers looking to develop and optimize immunodiagnostic assays.

Calypte is the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot. They sold this laboratory-based diagnostic test business to Maxim Biomedical Corp. in 2005. However, they continue to maintain a partial financial interest in the products.

The Company is also the licensed manufacturer of a unique, quantitative enzyme immunoassay developed by the U.S. Centers for Disease Control and Prevention (CDC). It can discriminate between recent and established HIV-1 infections. It is designed for use in epidemiology. The Aware™ BED™ EIA is the only practical way to determine HIV-1 incidence (how fast HIV is spreading in a given population) rather than prevalence.

For this year, Calypte remained focused on their strategy of increasing marketing and sales in the countries where their products are registered. They also continue to focus on seeking additional product registrations in countries where they have a high likelihood of making sales. Furthermore, they are planning for the clinical trials of Aware™ 2 and working on keeping their operating costs low.

Calypte Biomedical Corp. (CBMC), closed Wednesday’s session at $0.0029, even for the day, on 100 volume with 1 trade. The average volume for the last 60 days is 256,772 and the stock's 52-week low/high is $0.0026/$0.019.

Prophecy Coal Corp. (PCY.TO)

Today we are highlighting Prophecy Coal Corp. (PCY.TO), here at the QualityStocks Daily Newsletter.

Based in Vancouver, British Columbia, Prophecy Coal Corp. engages in developing energy projects in Mongolia. Their wholly owned subsidiary Prophecy Power Generation, LLC, is advancing plans for a proposed 600 MW mine-mouth power plant, which has been permitted by the Mongolian government, adjacent to the Company's Chandgana coal deposit. Prophecy Coal's shares trade on the Toronto Stock Exchange.

Another Prophecy Coal wholly owned Mongolian subsidiary is Chandgana Coal, LLC. The expectation is that this subsidiary will supply 3.5 million tonnes of coal annually to Prophecy Power for 25 years. Chandgana Coal controls more than 1.2 billion tonnes of thermal coal in the measured and indicated categories. This includes two mining licenses containing 141 million tonnes of measured resource with a strip ratio of 0.7:1.

Substantially all of the Company's resources are not mineral reserves; therefore, they do not have demonstrated economic viability. The Company cautions that the Chandgana project is in Mongolia and requires significant capital to develop.

The timeline for Prophecy Coal concerning the Chandgana Power Plant Project is to finalize the EPC contractor this year and finalize the PPA in Q1, 2013. The Company also plans to conclude the developer Joint Venture (JV) process in Q1 2013. The estimated time of the start of construction is Q1 2013, and the estimated start up power phase 1 is in Q1 2016.

Last week, Prophecy Coal announced the appointment of Mr. Jeffrey Mason as Chief Financial Officer.  Mr. Mason is a Chartered Accountant with more than 20 years experience in financial reporting. He's worked with a variety of medium and large publicly traded mining companies in the area of accounting, corporate finance and regulatory reporting.

Today, Prophecy Coal announced that they entered into a Memorandum of Understanding (MOU) with one of the world's largest power generation groups with installed capacity of more than 100 gigawatts and annual power generation of more than 450,000 gigawatt hours. The MOU is to develop, jointly, the Company's Chandgana Power Plant project in Mongolia. The Strategic Partner completed preliminary due diligence on the Project, including a site visit. This Strategic Partner also held several months of discussions with Prophecy Coal before signing the MOU.

Prophecy Coal Corp. (PCY.TO), closed Wednesday’s session at $0.14, up 7.69%, on 2,081,754 volume. The stock's 52-week low/high is $0.16/$0.61.

Native American Energy Group, Inc. (NAGP)

StockLockandLoad, StockBomb.com, StockRockandRoll, and PennyStockLocks.com reported earlier on Native American Energy Group, Inc. (NAGP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Forest Hills, New York, Native American Energy Group, Inc. is an independent energy resource development and management company. The Company has three principal projects: oil & gas, coal-bed methane natural gas (CBM), and planned, wind turbine power generation technology. They engage in the acquisition and management of Native American land and fee land acreage in Montana and Alaska; and the exploration for and development of oil and natural gas properties. Native American Energy Group lists on the OTCQB.

The Founders, upon the establishment of the Company, initiated their current philosophy of commitment and dedication to American Indian Nations. The American Indian Nations have abundant natural resources, but very few opportunities to develop them. The Founders, Officers, and Directors of Native American Energy Group have spent many years familiarizing themselves with the various tribes, their cultures, organizational structure and protocol. The Company and their Founders have received recognition by key Tribal members in the United States for their dedication and commitment to bettering the economic conditions of such Tribes through developing the energy resources on their reservations.

Native American Energy's projects include the development of oil and gas interests in the Williston Basin in Montana. They also include the development of coal-bed methane natural gas (CBM) in the Cook Inlet Basin in Alaska. In addition, projects include Vertical Axis Wind Turbine (VAWT) power generation technology implementation. This is for the production of clean, cost-efficient green energy throughout the U.S., including Alaska and all U.S. Native American Indian reservations.

In early October, Native American Energy announced that they began oil production on two wells in the Williston Basin in northeastern Montana. Production is currently taking place at the Wright 5-35 and Beery 2-24 wells. In addition to the two wells now in production, the Company currently owns a 100 percent working interest in three oil wells in Montana. These include the Beery 22-24, Cox 7-1 and the Sandvick 1-11. Native American Energy, subject to obtaining adequate financing, intends to complete both Beery wells during the remainder of 2012 and the Cox and Sandvick wells by the summer of 2013.

Native American Energy Group, Inc. (NAGP), closed Wednesday’s session at $0.195, up 8.33%, on 30,544 volume with 10 trades. The average volume for the last 60 days is 42,024 and the stock's 52-week low/high is $0.10/$6.00.

Natural Health Trends Corp. (NHTC)

SmallCapVoice reported earlier on Natural Health Trends Corp. (NHTC), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 2001, Natural Health Trends Corp. is a global direct selling and e-commerce company. They operate via their subsidiaries throughout Asia, North America, and Europe. Natural Health Trends markets premium quality personal care products under the NHT Global brand. With corporate headquarters in Dallas, Texas, the Company lists on the OTCQB.

Natural Health Trends majority-owned subsidiaries have an active physical presence in North America; Greater China, which consists of Hong Kong, Taiwan and China; South Korea; Japan; Russia; and Europe, which consists of Italy and Slovenia.

By way of subsidiaries operating under the name "NHT Global," Natural Health Trends engages in the direct selling industry, selling lifestyle enhancement products, cosmetics, personal care and dietary supplements. More specifically, they are engaging in network marketing or multi-level marketing. NHT Global distributors receive compensation for sales generated by distributors they have recruited and all subsequent distributors recruited by their "down-line" network of distributors.

The NHT Global division is one of the fastest growing direct selling companies worldwide. They have created, and they distribute, innovative personal care products with an emphasis on skin care. NHT Global has quickly expanded into many countries worldwide with products selling through these aforementioned independent distributors.

Yesterday, Natural Health Trends announced financial results for the third quarter and nine-month period ended September 30, 2012. Third Quarter financial highlights include total revenues of $9.3 million compared to $10.6 million for the same period in 2011, a decrease of 11.6 percent. The decrease in revenues for the third quarter reflects the promotional event during 2011 related to their 10-year anniversary celebration in Hong Kong, which did not benefit 2012. Net income attributable to common stockholders of the Company was $743,000, or $0.07 per basic and diluted share, compared to net income of $1.6 million, or $0.15 per basic and diluted share the year prior.

Net sales for the nine months ended September 30, 2012 were up $6.5 million, or 28.1 percent, to $29.4 million from $22.9 million in the same period a year ago. Year-to-date net income attributable to common stockholders of Natural Health Trends increased 14.9 percent to $2.1 million from $1.8 million in the same period last year.

Natural Health Trends Corp. (NHTC), closed Wednesday’s session at $1.17, up 4.46%, on 11,100 volume with 8 trades. The average volume for the last 60 days is 4,449 and the stock's 52-week low/high is $0.51/$1.88.


The QualityStocks
Company Corner


Cardium Therapeutics, Inc. (CXM)

The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.19, up 2.70%, on 123,027 volume with 126 trades. The stock’s average daily volume over the past 60 days is 204,538, and its 52-week low/high is $0.1771/$0.425.

Cardium Therapeutics, Inc. reported Q3 financials today for 2012 (ended Sept 30) and detailed several of the notable accomplishments successfully undertaken by the company, including the acquisition of the To Go Brands® business assets and 25-item nutraceutical supplement product portfolio (first three quarters of 2012 net sales of some $2.1M), formation of the advanced wound care-focused Excellagen® Medical Advisory Board, and recent presentations at the Desert Foot 9th Annual High Risk Diabetic Foot Conference showcasing the revolutionary potential of the company's leading Excellagen product. Additionally, the CE Mark obtainment for Excellagen expected to clear by 2013 showed profound movement on the international scene for CXM, even as Excellagen was featured in Podiatry Management's Profiles in Excellence for 2012 (Oct edition), and named one of the top ten podiatry innovations for 2012 by Podiatry Today.

Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.

The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.

Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.

Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer

Cardium Therapeutics, Inc. Company Blog

Cardium Therapeutics, Inc. News:

Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments

Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference

European Union's First Gene Therapy Approval Represents Major Advancement For Industry

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.011, up 15.79%, on 100,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 227,780, and its 52-week low/high is $0.001/$0.018.

Consorteum Holdings, Inc. was happy to report filing their 10-K with the SEC for the fiscal year (ended June 30) and a return to issuer status on the OTCQB. The company also announced that Mr. Fielding has resumed his roles as Chairman and CEO, as CSRH shifts to focus its energies on promising opportunities for the remainder of 2012 and beyond, including processing and transaction management initiatives both in North America and in the new overseas markets. Leveraging existing relationships with various casinos and resorts throughout these markets, while gearing for mobile gaming and wagering transactions, is a solid strategy and Fielding asserted that emphasis on the company's traditional transaction management, technology, and card businesses would continue alongside the launch of new initiatives.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission

CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming

DoMark International, Inc. (DOMK)

The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.3749, up 2.71%, on 63,340 volume with 29 trades. The stock’s average daily volume over the past 60 days is 68,354, and its 52-week low/high is $0.32/$4.88.

DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.

Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.

Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.

The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer

DoMark International, Inc. Blog

DoMark International, Inc. News:

DoMark Subsidiary SolaWerks Next Generation Technology Slated for Release

Hot on the Heels of the Freshly Launched Apple Mini Tablet, SolaWerks Prepares to Unveil the Ultimate Apple Accessory - the Latest SolaCase

DoMark International Inc. wholly-owned subsidiary MuscleFoot Inc. Sponsored UFC Fighters Evan Dunham and Igor Pokrajac in UFC 152, Sept 22

Loans4Less.com, Inc. (LFLS)

The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.094, up 17.50%, on 64,967 volume with 12 trades. The stock’s average daily volume over the past 60 days is 9,573, and its 52-week low/high is $0.01/$0.51.

Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.

Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.

The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.

Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer

Loans4Less.com, Inc. Company Blog

Loans4Less.com, Inc. News:

Loans4Less.com Provides Preliminary Financial Results for the Third Quarter of 2012

Loans4Less.com, Inc. New Audio Interview With Chairman and CEO Steven M. Hershman

Loans4Less.com, Inc. Announces Engagement of QualityStocks Investor Relations Services.

Cardium Therapeutics, Inc. (CXM) Presents Q3 Results, Plus Update on Business Activity

Cardium Therapeutics, a health sciences and regenerative medicine company, today presented financial results for the third quarter, ended September 30, 2012. The company also reported on recent developments, including the acquisition of To Go Brands nutraceutical brand platform, and various developments with Cardium’s Excellagen collagen-based topical gel for the treatment of wounds.

Cardium reported a net loss of $1.9 million for the three months ended September 30, 2012, compared to a net loss of $1.6 million for the three months ended September 30, 2011. The increase in loss was due primarily to an increase in costs, resulting from expenses related to the commercial development of Excellagen and the company’s Generx ASPIRE clinical study.

Selling, general and administrative expenses for the three-month period ended September 30, 2012, were $1.4 million, compared to $1.2 million for the three months ended September 30, 2011. For the nine months ended September 30, 2012, selling, general and administrative expenses were $4.4 million, compared to $3.6 million for the nine months ended September 30, 2011. The increase in selling, general and administrative expenses for the nine-month period was primarily due to expenses related to the costs associated with the market introduction of Excellagen and preparations to support and facilitate strategic partnering activities, and for Cardium’s nutraceutical initiative, which served as the catalyst for Cardium’s recent acquisition of the business assets of To Go Brands, Inc., which includes a portfolio of more than 25 products sold through mass, food and drug channels at retailers including Whole Foods®, CVS®, Kroger®, GNC®, Jewel-Osco®, Ralph’s Supermarkets®, Meijr® and the Vitamin Shoppe®, in addition to the company’s web-based store.

Cardium’s Quarterly Report on Form 10-Q filed with the SEC today presents in footnote unaudited pro forma consolidated financial information which includes To Go Brands for the period ended September 30, 2012 and 2011. The pro forma financial information includes net sales of To Go Brands for the nine months ended September 30, 2012, totaling $2.1 million, with a net loss of $0.4 million.

Continue Reading...

For additional information, visit www.CardiumTHX.com

Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report with SEC

Consorteum Holdings just announced that it filed its Report on Form 10-K for the fiscal year ended June 30, 2012, with the Securities and Exchange Commission and resumed its status as an issuer quoted on the OTCQB.

The company also told investors that some of its affiliates, as well as Consorteum, entered into a settlement agreement with its former CEO and Chairman of its Board of Directors. The settlement agreement was filed as an exhibit to the Form 10-K Report. Subsequent to the execution of this agreement, Consorteum and its former CEO executed and delivered to each other general releases.

Mr. Fielding has resumed his roles as Chairman and CEO. Now redirecting its energies on promising opportunities for the remainder of 2012 and beyond, Consorteum Holdings is very focused on executing processing and transaction management initiatives both in North America and in new overseas markets. The company will leverage its existing relationships with various casinos and resorts while pursuing growth through mobile gaming and wagering transactions.

“This is an exciting time for the world of mobile digital media as state and local governments are looking for creative alternatives to raise revenue. Mobile gaming is one possible revenue enhancer,” stated Craig Fielding, CEO of Consorteum Holdings. “We remain focused on our traditional transaction management, technology and card businesses. Now with the addition of new opportunities utilizing our mobile gaming platform, we are ideally positioned to step into new markets in a meaningful way.”

“I am optimistic that we can demonstrate to our shareholders that the past year of establishing key relationships across multiple verticals in the financial transaction processing and gaming businesses will translate into revenue opportunities for the Company,” added Mr. Fielding. “In the next several months we intend to launch new projects that are in the final stages of planning and will soon be ready for announcement. We also intend to continue our efforts to build a strong management team, Board of Directors and relationships with new partners.”

For more information about the company, visit www.consorteum.com

DoMark International, Inc. (DOMK) Rescues the Good Idea

It’s an unfortunate fact of business life that good ideas, even great ideas, are a dime a dozen. There isn’t a person alive that hasn’t had an idea pop into their head for a new product, a new service, a new technology, or just a new way of doing things. Ideas come from the recognition of a market need, even if the market itself doesn’t yet recognize it, and everyone occasionally becomes aware of a need. Of course, out of the thousands, even millions of good ideas out there, only a relative handful ever spark a working business, a startup that is put together to turn an idea into a profitable reality. And, of all the startups that are born of hope, few last for long. Because a good idea is only one part of a good business.

In many cases, the problem is that the founders of a startup often find themselves overwhelmed by all of the details of setting up and running a company. Instead of focusing on developing their good idea, they find themselves inevitably caught up in the struggle to survive. Too often they simply don’t have the skill set necessary to bring together all of the financial and human resources needed to make the business a success. It’s a serious gap, resulting in a lot of good ideas that never get realized.

DoMark is focused on filling that gap, by carefully researching and acquiring private firms that are struggling to bring their good ideas to market. DoMark is able to bring in the financial and human capital that so many startups need, allowing the principals to concentrate on developing and growing their ideas. Although DoMark is actively driving to expand into a variety of market areas, such as medical, energy, and business services, it is currently working with companies in the sports/health and mobile technology fields through its two wholly owned subsidiaries:

• SolaWerks, Inc., a new company developing and marketing cutting-edge products in the burgeoning consumer electronics industry, including cover and charging systems for mobile devices

• MuscleFoot, Inc., sellers of products based on a revolutionary and patented foot care system called Barefoot Science

For a full investor kit on DOMK, go to www.domk.qualitystocks.net

Quaterra Resources, Inc. (QMM) Shows Solid Intervals Like 2.62 feet at 54.5 Ounces Per Ton Silver in Newly Discovered Zone at Nieves Project

Quaterra Resources today reported excellent evidence of their model for the Nieves silver property in northern Zacatecas, Mexico, as assay results on eight core holes drilled (just over 10k feet total) from August through October come in via the company and its 50% JV partner, Blackberry Ventures I, LLC, offering positive correlation that there is indeed a sizeable, high-level hydrothermal system, potentially stretching well out beyond extant discoveries.

Project Manager at the Nieves, Hector Fernandez, noted the long running analytical modality at QMM which projected the vein system’s extents considerably further to the west and how the intersection of 2.62 feet at 54.5 ounces per ton silver in Hole QTA 190 roundly validates the anticipated existence of this larger vein interval, beginning at around 800 feet (average grade of 10 opt Ag). Collaring of the hole to test this westward extension, the Orion vein (considered a projection of the established Gregorio vein 1.2 miles east of the hole), for an induced polarization (IP) anomaly, in concert with the other drilling, gives a clear map of the mineralization.

Wildcat holes drilled some 6,500 feet out beyond QTA 185-187 (which tested IP and geochemical vectors on the western Santa Rita vein arm and returned some choice gold values indicating strong potential for a deeper, undiscovered silver body), showed no anomalous vein occurrences/mineralized intersections and gives a clear outline to the rich discoveries. QTA 186 and 187 in particular offer strong evidence, having produced 16.7-foot intervals at average grades of 0.7 g/t and 0.55 g/t gold, making the potential for considerable silver mineralization below a clear geological extrapolation.

QTA 191/192 put in some 656 feet west and east (respectively) of QTA 190, right in the heart of the new target zone, returned 2.79 feet at 289 g/t Ag and 3.6 feet at 284 g/t, and with the entire zone open laterally and at depth, we have an exceptional development opportunity here with an abundant feature set. Big news for QMM who continues to post exciting mineral news like this, with today’s discovery coming so shortly after the (Oct 31) announcement that they intersected high-grade gold during the summer 2012 diamond drilling program up at the Herbert Gold Project outside Juneau, Alaska. The company has put up accompanying maps and tables for the Nieves Project on their corporate site with further details and investors are encouraged to take a closer look at the company’s rapidly emerging portfolio of interests.

QMM’s got a nice foundation of copper in the U.S. with very enticing gold/silver projects in Mexico and other mining-friendly locales. The company has the management and technical muscle to make their considerably large and growing pipeline of assets into a real shareholder return powerhouse.

Qualified Person for today’s report was QMM President and CEO, Thomas C. Patton, B.Sc., M.Sc., Ph.D., with core samples handled by ALS Chemex facilities in Guadalajara and Vancouver. Extensive testing included routine insertion of property-specific standards with each sample batch, an initial 35-element ICP battery (with aqua regia digestion), as well as a complete 30-gram fire assay (gravimetric finish for Au/Ag). ICP results are offered for Ag up to 100 g/t with fire assay for anything over that amount, and the samples with over one percent of lead, copper, and/or zinc being handled by AA with aqua regia digestion.

For more information on Quaterra Resources, please visit www.Quaterra.com


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Wall Street Resources



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251